[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=91385]], camposKey:1473-9542 2025-12-01 Exploring the role of splicing in TP53 variant pathogenicity through predictions and minigene assays00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=91384]], camposKey:2056-7944 2025-12-01 TP53 minigene analysis of 161 sequence changes provides evidence for role of spatial constraint and regulatory elements on variant-induced splicing impact00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=91386]], camposKey:0946-2716 2025-01-01 Unproductive alternative splicing of ATM exon 7: mapping of critical regulatory elements and identification of 34 spliceogenic variants00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=91387]], camposKey:2072-6694 2024-11-01 Splicing Dysregulation of Non-Canonical GC-5¿ Splice Sites of Breast Cancer Susceptibility Genes ATM and PALB200, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87008]], camposKey:2234-943X 2024-01-01 Chloroquine-induced DNA damage synergizes with DNA repair inhibitors causing cancer cell death00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=86995]], camposKey:0022-3417 2024-01-01 Comprehensive splicing analysis of the alternatively spliced CHEK2 exons 8 and 10 reveals three enhancer/silencer-rich regions and 38 spliceogenic variants395409, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80974]], camposKey:2076-3921 2023-09-01 Predominantly Pro-Inflammatory Phenotype with Mixed M1/M2 Polarization of Peripheral Blood Classical Monocytes and Monocyte-Derived Macrophages among Patients with Excessive Ethanol Intake00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75196]], camposKey:1355-008X 2023-04-01 The p.Pro2232Leu variant in the ChEL domain of thyroglobulin gene causes intracellular transport disorder and congenital hypothyroidism4753, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81175]], camposKey:0022-3417 2023-01-01 Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline <i>PALB2</i> splice-site variants (vol 256, pg 321, 2022)372373, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81167]], camposKey:0009-9147 2023-01-01 Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site Variants , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75407]], camposKey:1471-2407 2022-12-01 Polymorphisms in autophagy genes are genetic susceptibility factors in glioblastoma development00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75197]], camposKey:0022-3417 2022-09-01 Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variants83101, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75557]], camposKey:2072-6694 2022-09-01 Splicing Analysis of 16 PALB2 ClinVar Variants by Minigene Assays: Identification of Six Likely Pathogenic Variants00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75558]], camposKey:2072-6694 2022-06-01 Minigene Splicing Assays Identify 20 Spliceogenic Variants of the Breast/Ovarian Cancer Susceptibility Gene RAD51C00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73053]], camposKey:1355-008X 2022-06-01 Mutational screening of the TPO and DUOX2 genes in Argentinian children with congenital hypothyroidism due to thyroid dyshormonogenesis86101, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65172]], camposKey:0022-3417 2022-03-01 Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variants321334, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75559]], camposKey:2072-6694 2022-02-01 Germline Variants of CYBA and TRPM4 Predispose to Familial Colorectal Cancer00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60657]], camposKey:2072-6694 2021-01-01 Rad51d aberrant splicing in breast cancer: Identification of splicing regulatory elements and minigene-based evaluation of 53 dna variants28450, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=86994]], camposKey:2072-6694 2020-01-01 Comprehensive functional characterization and clinical interpretation of 20 splice-site variants of the RAD51C gene00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54972]], camposKey:0909-752X 2020-01-01 Multiple familial trichoepitheliomas: Ultrasonographic findings137139, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54973]], camposKey:1610-0379 2019-01-01 Comparative genomic hybridization analysis of basal cell carcinoma197200, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54974]], camposKey:0007-0963 2018-01-01 Evidence of the high prevalence of neurological disorders in nonsyndromic X-linked recessive ichthyosis: a retrospective case series933939, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54975]], camposKey:0303-7207 2018-01-01 Molecular analysis of thyroglobulin mutations found in patients with goiter and hypothyroidism116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54976]], camposKey:0007-0963 2018-01-01 Novel clinical and molecular findings in Spanish patients with naevoid basal cell carcinoma syndrome198206, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54977]], camposKey:0007-0963 2017-01-01 A case of mosaicism in ectodermal dysplasia¿skin fragility syndrome00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54979]], camposKey:0007-0963 2017-01-01 Familial seborrhoeic keratosis associated with multiple `pure reticulated acanthomas¿ and infundibulocystic basal cell carcinomas16541663, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54978]], camposKey:0926-9959 2017-01-01 Novel mutations in FATP4 gene in two families with ichthyosis prematurity syndrome00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54980]], camposKey:0926-9959 2016-01-01 Acral peeling skin syndrome resulting from mutations in TGM5477480, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54983]], camposKey:1769-7212 2015-01-01 A new mutation in the COL4A3 gene responsible for autosomal dominant Alport syndrome, which only generates hearing loss in some carriers3538, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54984]], camposKey:0019-5154 2015-01-01 Emopamil binding protein mutation in Conradi-Hünermann-Happle syndrome representing plaque-type psoriasis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54982]], camposKey:0303-7207 2015-01-01 Novel compound heterozygous Thyroglobulin mutations c.745+1G>A/c.7036+2T>A associated with congenital goiter and hypothyroidism in a Vietnamese family. Identification of a new cryptic 5' splice site in the exon 6102112, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54981]], camposKey:1420-4096 2015-01-01 Study of the true clinical progression of autosomal dominant alport syndrome in a European population435442, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54987]], camposKey:1948-1756 2014-01-01 COL4A4 gene study of a european population: Description of new mutations causing autosomal dominant alport syndrome177184, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54985]], camposKey:0007-0963 2014-01-01 Early-onset acral basal cell carcinomas in Gorlin syndrome12271229, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54986]], camposKey:0007-0963 2013-01-01 Molecular evidence of type 2 mosaicism in Gorlin syndrome13421345][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=33901]},camposKey: 247 260 Docencia basada en la evidencia 978-84-18583-04-9Innovación docente en Educación Superior: interacción, participación y colaboración 1 2023-01-01 Agilice Digital][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62764]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=65580]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=65581]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62764]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=65580]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=65581]]][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=814]]][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=814]]][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=31424]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@725179ef, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@78765b78, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2e882bee, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@32a07a05, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4b47f3bf, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@1a0dc34, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6e1840b5, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5fd97f21, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2bf7a56e, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2c318d58, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7d83, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@14b42ad5, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@27e31f8, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@228537a2][][][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c17fa], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c17fb], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c17fd], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c17fe], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c17ff], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c1802], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c1804], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c1803], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c1805]][][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@17b35, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1714a, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@17aac, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1706a][]
